Printer Friendly

United States Department of Health and Human Services obtains United States patent.

United States Department of Health and Human Services (Washington, DC) has patented a chimeric parainfluenza viruses (PIVs) that incorporate a PIV vector genome or antigenome and one or more antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. These chimeric viruses are infectious and attenuated in humans and other mammals and are useful in vaccine formulations for eliciting and immune responses against one or more PIVs, or against a PIV and non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric PIV genome or antigenome which includes a partial or complete PIV vector genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) encoding antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. In preferred aspects of the invention, chimeric PIV incorporate a partial or complete human PIV vector genome or antigenome combined with one or more heterologous gene(s) or genome segment(s) from a heterologous PIV or non-PIV pathogen, wherein the chimeric virus is attenuated for use as a vaccine agent by any of a variety of mutations and nucleotide modifications introduced into the chimeric genome or antigenome. (US 7,314,631)
COPYRIGHT 2007 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Dec 1, 2007
Words:196
Previous Article:Myriad Genetics obtains United States patent.
Next Article:California drug and alcohol clinic becomes the first in the nation to offer DNA-customized treatment for individuals with a genetic predisposition...
Topics:


Related Articles
Advanced Tissue Sciences receives patent for growing living cartilage with mesenchymal stem cells.
University of Utah awarded United States patent for use of dye in PCR.
Hoffmann-La Roche $1 billion lawsuit filed by Promega.
MorphoSys widens scope of United States patent for HuCAL technology.
Federal Court of Appeals to decide on claims for United States in fraud case against Hoffmann-La Roche.
Department of Health and Human Services obtains United States patent.
United States Department of Health and Human Services obtains United States patent.
United States of America, Represented by the Secretary, Department of Health and Human Services obtains United States patent.
United States Secretary of the Department of Health and Human Services obtains United States patent.
United States Department of Health and Human Services obtains United States patent.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters